News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Boyle Kevin S. Sr.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Boyle Kevin S. Sr. (CEO) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Granted 1,800,000 options to buy
@ $0.5, valued at
$900k
|
|
| 09/01/2022 |
4
| Boyle Kevin S. Sr. (CEO) has filed a Form 4 on Alaunos Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 18,750 shares
@ $2.41, valued at
$45.2k
|
|
| 04/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Boyle Kevin S. Sr. (CEO) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Bought 884 shares
@ $1.4, valued at
$1.2k
Bought 9,116 shares
@ $1.4, valued at
$12.8k
|
|
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|